18643-84-0

Usage

Uses

Used in Plastic Industry:
Dimethyl chloroterephthalate is used as a key component in the production of polyethylene terephthalate (PET) for its versatility and strength, making it suitable for manufacturing plastic bottles, containers, and films.
Used in Polymer Production:
Dimethyl chloroterephthalate is used as a monomer in the synthesis of various polymers, contributing to their structural integrity and performance characteristics in different applications.

InChI:InChI=1/C10H9ClO4/c1-14-9(12)6-3-4-7(8(11)5-6)10(13)15-2/h3-5H,1-2H3

Upstream product

• 67-56-1 methanol 
• 1967-31-3 2-chloroterephthalic acid 
• 74-88-4 methyl iodide 
• 95-72-7 2-chloro-1,4-dimethyl-benzene 
• 7697-25-8 2-chloro-4-methylbenzoic acid 
• 10312-55-7 3-aminoterephthalic acid 

Downstream Products

• 431888-57-2 2-chloro-4-(methoxycarbonyl)benzoic acid 
• 55737-77-4 2-chloro-1,4-benzenedicarboxylic acid,1-methyl ester 
• 431888-58-3 1-tert-butyl 4-methyl 2-chloroterephthalate 
• 1190947-53-5 tert-butyl 2-chloro-4-(hydroxymethyl)benzoate 
• 879088-82-1 tert-butyl 4-(bromomethyl)-2-chlorobenzoate 
• 1190947-56-8 tert-butyl 2-chloro-4-(methylsulfonylmethyl)benzoate 
• 879087-10-2 2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonylmethyl)benzamide 
• 1190947-57-9 2-chloro-4-(methylsulfonylmethyl)benzoic acid 

Relevant academic research and scientific papers

PREPARATION OF TRANS,TRANS MUCONIC ACID AND TRANS,TRANS MUCONATES

The present invention relates to the isomerization of cis,cis and/or cis,trans muconic acid or esters thereof to trans,trans muconic acid or esters thereof and to the esterification of such muconic acids.

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

The invention provides novel inhibitors of hedgehog signaling that are useful as s therapeutic agent for treating malignancies where the compounds have the general formula (I): where A, X, Y R1, R2, R3, R4, m and n are as described herein.

Pyridyl inhibitors of hedgehog signalling

The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R1, R2, R3, R4, m and n are as described herein.

Process and intermediates for the preparation of halogenated protease inhibitors

This invention relates to novel intermediate compounds which are useful for producing the halogenated protease inhibitors that are the subject matter of U.S. Pat. No. 4,469,885. In particular, the invention relates to novel methods and intermediates for making said protease inhibitors, the intermediate compounds being of the formula: STR1 wherein R1 is: (a) straight or branched chain lower alkyl having 1-6 carbon atoms; or (b) H; wherein R6 is: (a) straight or branched chain higher alkyl having 13-25 carbon atoms; or (b) straight or branched chain higher alkenyl having 13-25 carbon atoms; wherein R5 is: (a) straight or branched chain lower alkyl having 1-6 carbon atoms; or (b) benzyl; wherein R7 is: (a) straight or branched chain lower alkyl having 1-6 carbon atoms; or (b) H; wherein R2 is: (a) --Cl, --Br, or --I; or (b) --CF3.